Xencor, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $82.74 | $2.72 B | -49.3 | 130 | $110.32 M |
 ANAB
|
AnaptysBio, Inc. | $31.88 | $640.07 M | -3.82 | 117 | $17.16 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 ERAS
|
Erasca, Inc. | $2.68 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.07 | $1.65 B | -11.47 | 97 | $0 |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.17 | $243.38 M | -1.59 | 129 | $0 |
 IDYA
|
IDEAYA Biosciences, Inc. | $30.77 | $2.88 B | -19 | 124 | $23.39 M |
 KROS
|
Keros Therapeutics, Inc. | $56.50 | $1.76 B | -9.45 | 149 | $151,000 |
 KURA
|
Kura Oncology, Inc. | $19.51 | $1.66 B | -10.03 | 142 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.58 | $611.84 M | -9.99 | 42 | $0 |
 MGTX
|
MeiraGTx Holdings plc | $4.26 | $306.74 M | -4.01 | 387 | $14.02 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $11.91 | $652.38 M | -6.03 | 28 | $0 |
 MRUS
|
Merus N.V. | $47.76 | $3.50 B | -19.38 | 172 | $43.95 M |
 NUVL
|
Nuvalent, Inc. | $99.00 | $5.11 B | -32.72 | 115 | $0 |
 PCVX
|
Vaxcyte, Inc. | $113.14 | $7.72 B | -16.54 | 254 | $0 |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.54 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $11.16 | $485.18 M | -2.44 | 331 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.90 | $1.66 B | -6.02 | 184 | $0 |
 STRO
|
Sutro Biopharma, Inc. | $3.50 | $303.46 M | -1.97 | 304 | $153.73 M |
 VRDN
|
Viridian Therapeutics, Inc. | $23.31 | $776.72 M | -2.71 | 94 | $314,000 |